Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

Clinical Trial Linker

Query ClinicalTrials.gov for active and recent trials. Responses are cached for 24 hours; offline fixtures cover well-known drugs.

Search by approved-drug name. Autocomplete pulls from the 92-drug KIRhub catalog.

Trial timeline (1)

Trial table

NCTTitlePhaseStatusInterventionsDates
NCT07567469A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A EpendymomaPHASE1, PHASE2NOT_YET_RECRUITINGCemiplimab, Cemiplimab+Fianlimab Fixed Dose Combination (FDC)2026-08-312034-08-17